ࡱ> )` RAEbjbjv{{       & 8lR4& [Z[[[[[[$]h_:%[Q qt"qq%[  v[999qH  Z9qZ99jN  U 0P Q2Z\[0[QJ0aApadU,CU0aLa$ W(h9T%[%[X[qqqq& & & $ Jd& & & J& & &        Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limited(a joint stock company established in the People s Republic of China with limited liability)(Stock Code: 0719)VOLUNTARY ANNOUNCEMENTUPDATE ON THE RECENT DEVELOPMENT OFDISCLOSEABLE AND CONNECTED TRANSACTIONIN RELATION TO XINCAT PHARMACEUTICAL ACQUISITIONThis announcement is made by Shandong Xinhua Pharmaceutical Company Limited (the Company, together with its subsidiaries, the Group) on a voluntary basis. Reference is made to the announcement (the Announcement) of the Company dated 29 January 2014 and the circular (the Circular) of the Company dated 3 March 2014 in relation to the Xincat Pharmaceutical Acquisition and the subsequent announcement in relation to the EGM resolution. Capitalised terms not defined herein bear the same meanings as those defined in the Circular and the Announcement.The purpose of this announcement is to keep the shareholders and potential investors of the Company informed of the latest development in relation to the Xincat Pharmaceutical Acquisition.The Xincat Pharmaceutical AcquisitionAt the EGM held on 18 March 2014, a resolution was passed by the Shareholders to approve the bidding by the Company of the 40% of the equity interest in Xincat Pharmaceutical (the  Relevant Equity Interest ) at a price of not more than RMB112 million at the Shandong Property Right Exchange Center ( q\qg"u kN-N_) and upon such bidding being successful, the entering into the Acquisition Agreement in respect of the Relevant Equity Interest between the Company and Hualu Holdings and the transactions contemplated thereunder.As disclosed in the Announcement and the Circular, the tender process of the Shandong Property Right Exchange Center provided that if the Company succeeded in the bidding, the Company would be required to enter into the Acquisition Agreement and proceed with the Xincat Pharmaceutical Acquisition (the Procedure) as follows:within 2 working days of the confirmation of the successful bidding of the Relevant Equity Interest by the Company, the Company would enter into the Acquisition Agreement with Hualu Holdings; andwithin 2 working days after the entering into of the Acquisition Agreement, the Company would have to pay the balance of the purchase price into the account designated by Shandong Property Right Exchange Center.In view of the Procedure set out above, the Company applied to the Stock Exchange for and was granted a waiver from strict compliance with Rules 14.34 and 14A.47 of the Listing Rules. On 18 March 2014, the Company obtained a prior mandate from the Shareholders at the EGM to bid for the Relevant Equity Interest at the maximum bidding price of not more than RMB112 million. UPDATE ON THE RECENT DEVELOPMENT OF THE TENDER PROCESSThe tender process in relation to the Relevant Equity Interest is still ongoing and the bidding of the Relevant Equity Interest has not yet taken place.Separately, it has recently come to the attention of the Company that another proposed transferee (an independent third party) (the Independent Third Party) has emerged during the tender process of the Relevant Equity Interest. As the Companys intended maximum bidding price has been disclosed publicly in the Circular and the Announcement, the Company considers it has been put at a disadvantage position when competing with the Independent Third Party in the bidding. Moreover, the Company has recently been informed that the Procedure has been amended. Under the amended Procedure, in case the Company succeeds in the bid, the Acquisition Agreement to be entered into between the Company and Hualu Holdings may be subject to Shareholders approval. Accordingly, the transaction under the Acquisition Agreement will only proceed and the balance of the purchase price shall only be paid after Independent Shareholders approval (if applicable) has been obtained.In view of the above and taking into account the current business of Xincat Pharmaceutical, the Board resolved on 25 August 2014 that a member of the Board or a member of the management of the Company be authorised to bid for the Relevant Equity Interest at an appropriate price (which may or may not exceed RMB112 million), taking into consideration development during the bidding period and the principle to act in the best interests of the Company and its Shareholders as a whole. In the event the Company successfully bids the Relevant Equity Interest at a price exceeding RMB112 million, the Company will comply with the relevant disclosure and/or shareholders approval requirements under Chapter 14 and Chapter 14A of the Listing Rules as well as the listing rules of the Shenzhen Stock Exchange.GENERALShareholders of the Company and potential investors should note that the Xincat Pharmaceutical Acquisition may or may not proceed and are advised to exercise caution when dealing in the securities of the Company. By Order of the Board Shandong Xinhua Pharmaceutical Company Limited Zhang Daiming Chairman25 August 2014, Zibo, PRC-Z [ q r s t u  x 0 2 V ξξξΤs]N>4hNCJKHaJhN6CJKHPJ]aJo(hN6CJKHPJ]aJ*hNB*CJOJPJQJ^JaJo(phhN5KHPJ\aJo( h\p.6KHPJ]aJnHtH#hN6KHPJ]aJnHo(tH3jhN5KHPJU\aJmHnHo(tHuhN6CJKHPJ]aJo(hN6CJKHPJ]aJhN6CJKH]aJo('hN6CJKHPJ]aJnHo(tHq s u v w  x 2 X Z \  A B $7$8$G$H$a$gd4g#$7$8$G$H$a$gd^? $7$8$H$a$gd4g#$a$ $7$8$H$a$$J7$8$H$a$gd\p. $7$8$H$a$$E@EV X Z \ @ A B _ n_SDh4g#h CJKHPJaJh;CJKHPJaJh4g#h4g#CJKHPJaJ"h[h[5CJKHPJaJo(h[CJKHPJaJh[CJKHPJaJo(h^?5CJKHPJ\aJh^?CJKHPJaJo(h^?CJKHPJaJh4g#CJKHPJaJ h4g#5\h4g#h4g#5\h=h[o(h=hNo(!hNCJKHPJaJnHo(tH 3BGKSZbhsz  12Rcqrs./1VXhvj^h&?JCJKHPJaJhK]CJKHPJaJhK]5CJKHPJaJh4g#CJKHPJaJh4g#hZ7CJKHPJaJh;CJKHPJaJh4g#h4g#CJKHPJaJh h;CJKHPJaJh CJKHPJaJo(h Rh 5CJKHPJaJh4g#h CJKHPJaJh CJKHPJaJ$ rs01WXbcopDE$7$8$G$H$^a$gd$ & F7$8$G$H$^`a$gdK]$7$8$G$H$a$gdK]$7$8$G$H$a$gd&?J$7$8$G$H$a$gd^?$7$8$G$H$a$gd4g#$7$8$G$H$a$gd hxJPt `bc,-05;UYef٧囏teXhK]5CJKHPJaJh4g#hK]CJKHPJaJhCjCJKHPJaJh&?Jhl=CJKHPJaJhl=CJKHPJaJhK]CJKHPJaJ"h&?JhlhlCJKHPJaJh&?Jh&?JCJKHPJaJo(hL^hl5CJKHPJaJhlCJKHPJaJh&?JCJKHPJaJh&?Jh&?JCJKHPJaJ+1ijnpCT]klmy4JXd|͵٩vgvvvXh&?Jho CJKHPJaJhSho CJKHPJaJho CJKHPJaJha.CJKHPJaJhS(hA=CJKHPJaJhA=CJKHPJaJhCJKHPJaJhxCJKHPJaJhCJKHPJaJhCjCJKHPJaJhK]CJKHPJaJhZ7hZ7CJKHPJaJhZ7CJKHPJaJ"34U\tu+.Wstuȼwj[jjOwhlCJKHPJaJhhcCJKHPJaJhcCJKHPJaJo(hhCJKHPJaJhSho CJKHPJaJho CJKHPJaJha.ha.CJKHPJaJh8CJKHPJaJha.CJKHPJaJ ho 5\hK]5CJKHPJaJhK]CJKHPJaJhCJKHPJaJhCJKHPJaJEijXY}~\]^x$ 7$8$G$H$^ `a$ $7$8$G$H$a$$7$8$G$H$a$gdP$7$8$G$H$a$gd^?$7$8$G$H$a$gdK] $7$8$H$a$gdK]$7$8$G$H$a$gdS( &al4DWnr!/ܷܷ螏tcVcVh1CJKHPJaJo(!h1CJKHPJaJnHo(tHhcCJKHPJaJh&?JhcCJKHPJaJhhCJKHPJaJhcCJKHPJaJo(hg3CJKHPJaJhc9CJKHPJaJhCJKHPJaJo(hS(CJKHPJaJh8CJKHPJaJhK]CJKHPJaJheCJKHPJaJ/02\]^ijpʺ֪ւsgւ[gNh5 CJKHPJaJo(hJCJKHPJaJhQwDCJKHPJaJhh& CJKHPJaJh(3CJKHPJaJhcCJKHPJaJo(h&?Jh)-CJKHPJaJh)-CJKHPJaJnHtHh) CJKHPJaJnHtHh) CJKHPJaJh& CJKHPJaJhg3CJKHPJaJo(hg3hg3CJKHPJaJo($%0;=?IJVh.ɽ񤘤zk\kLhhCJKHPJaJo(hPhQwDCJKHPJaJhPhsdCJKHPJaJhsdhsdCJKHPJaJh&?Jh5 CJKHPJaJhlCJKHPJaJh4CJKHPJaJo(h(3CJKHPJaJh& CJKHPJaJh5 CJKHPJaJo(hh(3CJKHPJaJhQwDCJKHPJaJhhCJKHPJaJ.?@JK{|}~ [\ŸyiYiYLi:"h&'hP5CJKHPJaJo(h;5CJKHPJaJh&'hYqO5CJKHPJaJh&'hP5CJKHPJaJhK]CJKHPJaJo(hK]CJKHPJaJhK]5CJKHPJaJhCJKHPJaJhCJKHPJaJo(hsdCJKHPJaJo(h1W$h1W$CJKHPJaJhQwDCJKHPJaJh1W$h;CJKHPJaJhh;CJKHPJaJo(\]^bxy|~ƶtetVeE!h1CJKHPJaJnHo(tHh,6CJKHPJ]aJhN6CJKHPJ]aJhN6CJKHPJ]aJo('hN5CJKHPJ\aJnHo(tHh,5CJKHPJ\aJhN5CJKHPJ\aJhN5CJKHPJ\aJo(hNCJKHPJaJh,CJKHPJaJ!hNCJKHPJaJnHo(tHh^?hPCJKHPJaJo(x;DE?E@EAE$`a$$a$$4$a$0E1E2E3E9E:E;EE?E@EAEhNCJPJaJnHo(tHhl&hS(CJPJnHtHhS(0Jo(h 0JmHnHu hS(0JjhS(0JUhS(hS(6CJ]o( 6 00&P P. A!"##$% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCB6666666666666666666666666666666666666666666666666hH666666666666666666666666666666666666666666666666666666666666666666D@D cke1$ CJKH_HaJmH nHsH tHh@h h 1&$$s@&^`sa$5B*CJOJQJ\^JphT@T h 2$$7$8$@&H$a$5CJ$KHOJQJ\aJ$H@H h 3$$ & F@&G$a$5\nHtHB@B h 4$$@&G$a$5\nHtH^@^ h 5"$$7$8$@&G$H$^a$5KHPJ\aJnHtH^@^ h 6!$$ & F7$8$@&G$H$a$5KHPJ\aJnHtH^@^ h 7!$$ & F7$8$@&G$H$a$5KHPJ\aJnHtH$A@$ ؞k=W[SOFi@F 0nfh 1,  [[  __ 8*urn:schemas-microsoft-com:office:smarttagsCity=*urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceNameB *urn:schemas-microsoft-com:office:smarttagscountry-region9 *urn:schemas-microsoft-com:office:smarttagsplace "   wvhn GM4;&69ekw 33`Kf'Cy[?~+/>INhlNC`|V|2sVPD,w6 4X *֊ou;$ZScVI4+XPT`XX ]r-J^s$bΩzk&iVlz+gl~oLu9sBu$]| hh^h`5o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`5o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .^`o(.D D^D` 0$  $ ^$ ` .   ^ ` .   ^ ` 0 ^` . ^` . ^` 0d d^d` .^`o(.( (^(` 0 ^` . ^` .   ^ ` 0   ^ ` . ^` .h h^h` 0H H^H` . ^` PJo(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .^`PJo(.D D^D` 0$  $ ^$ ` .   ^ ` .   ^ ` 0 ^` . ^` . ^` 0d d^d` .HH^H`o(() ^` 0 ^` .`  ` ^` ` .@  @ ^@ ` 0   ^ ` . ^` . ^` 0 ^` .^`o(.   ^ ` 0 ^` . ^` . ^` 0   ^ ` .l  l ^l ` .L L^L` 0, ,^,` .T0T^T`0o(()D D^D` 0$  $ ^$ ` .   ^ ` .   ^ ` 0 ^` . ^` . ^` 0d d^d` . ^` o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`PJo(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` . O ^O` hH. / ^/` hH0  ^` hH.  ^` hH.   ^ ` hH0   ^ ` hH.  ^` hH. o ^o` hH0 O ^O` hH.,,^,`o(. ^` 0d  d ^d ` .D  D ^D ` .$ $^$` 0 ^` . ^` . ^` 0 ^` .hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .^`o(() ^` 0 ^` .   ^ ` .|  | ^| ` 0\ \^\` .< <^<` . ^` 0 ^` .hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .::^:`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .^`o(.404^4`0o(()$  $ ^$ ` .   ^ ` .   ^ ` 0 ^` . ^` . ^` 0d d^d` .d0^`0PJo(. ^` 0 ^` .`  ` ^` ` .@  @ ^@ ` 0   ^ ` . ^` . ^` 0 ^` .hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`o(.HH^H`o(.((^(`o(. ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .HH^H`o(. ^` 0 ^` .`  ` ^` ` .@  @ ^@ ` 0   ^ ` . ^` . ^` 0 ^` .|9scVI$b~o+[?~6 -J^9s<" 9s<" 9s<" 9s9sXNhlX *]l]|+glXPTou;9sVC&i`X<" vm1ќbu1Du4U4W4gnŀK        0!        jb։        fL        ҅        fRi        ;j                Kz        NW        &nG        $        Zn        B$        X"        X        &DM        |6.       l,        ",p        [ >$      k         @ @@ @*;Hj%(*3Kcj^ q.r+*7LW~G.:[&bVehUe!?0">0j%:JmVw3*5F}+T{wG.0#y]C8/EZ(u0:[>0CiwR*29iqq|E5FhUe!Gm J(pD Kc*3K0|'NpD KCiwRdRRdRRz\CnT;H:JmVC8/z\CnT0#y]Gx j^m J&bqVe9dfiw3*iqqdfi.r*2EZ(uGxGT{?0".) j-#>TJ2T1J/LTl=& 4g##$1W$x%l&&'u*P*/',)-a.\p.UX0^0 1(3U3c9jQ9t=wP>"AQwDb E^F2WHJ&?JLaM>N O]OYqOP T.XkSXYK]s]^"x^u.bZ dsd(ef7i_iCjAnen-qxFxz+~Q~TQ5 &9Og3zi2`MNo l= D\ =mC(,ZiF9Rec[S(n/ Mw8EEvBV~,;X<U$^c]]Lrt~546Z7OfUN=PLk=^?r8[zz,8A= / R/&APGk,e"$rlKfBCMy0@' LwwwwfP@P P@PP$@P@UnknownGz Times New Roman5Symbol3& z Arial;[SOSimSunKM  DFKai-SBPMingLiUC .PMingLiUe0}fԚO Times-BoldPMingLiU 1h;(8(']|'G]- (]- (!?!),.:;?]}    " % & ' 2 t%00 0 000000013468:<>@BDOPQRTUVWZ\^ \]d([{  5 0 0 00000579;=?ACY[][DJqXZ $P<2~The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representationANDYLAWhggSf i Z'`IZ'd                 Oh+'0 ,<HX ht   The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representationANDYLAWNormal4Microsoft Office Word@G@5@bj@8 ]-՜.+,0 X`t|  Charltons( '   !"#$%&'()*+,-./0123456789:;=>?@ABCEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstvwxyz{|~Root Entry F0P Data <1TableDaWordDocumentvSummaryInformation(uDocumentSummaryInformation8}CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q